Avitar's Integrated Technology Simplifies Deployment Of Proven Solution To The Costly Problem Of Workplace Drug Abuse

Substance Abuse Management Solution (SAMSTM) Helps Corporations Implement Oral-based Random Testing, Capable of Reducing Illicit Drug Use by 8x

April 14, 2005

CANTON, Mass., April 14, 2005 – To assist corporations in the management of the $110B+ annual problem of drugs of abuse in the workplace, Avitar, Inc., (Amex: AVR - News) the leading supplier of on-site oral tests for drugs of abuse, today announced its Substance Abuse Management Solution (SAMS™). SAMS is an integrated technology and services framework, including oral-based on-site drug screens, software, and services, which enables organizations to develop, deploy and manage a workplace drug testing program.

The SAMS framework is based on Avitar’s ORALScreen® oral-based drug screening technology. Avitar’s oral on-site products enable random testing, proven to be the most effective form of workplace drug testing. The Company’s ORALscreen solution is also used for pre-employment, reasonable suspicion, post-accident, and return-to-duty testing use.

"Avitar’s clients have demonstrated that oral-based random on-site testing is the most effective deterrent to workplace drug abuse." said Pete Phildius, CEO of Avitar. "SAMS provides a turnkey solution for a corporation to establish and manage a random testing program, and thereby reduce the costs of having drug users on the payroll. National statistics show that it costs an employer $10,000 for each drug abuser on the payroll, or $1,000,000 for every 1,000 employees."

SAMS provides a "roadmap" and tools that enable a corporation to develop and implement a successful drug free workplace solution.

"The SAMS approach has proven to be successful." A spokesperson for one $40 billion international corporation said, "When we started our comprehensive on-site random oral drug screening program our positive rate was 7.0%. It has now dropped to 0.9%."